OncTimes Talk Por: Oncology Times OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology. 100 episodios disponibles Latest episodes of the podcast OncTimes Talk Mostrando página 3 de 5 Cardio-Oncology: Many Cancer Treatment Cardiotoxicities Still to Be Understood 14/10/2024 Emerging Potential for Cell Therapies in Ovarian Cancer and Other Solid Tumors 07/10/2024 Global Cooperation on Antibody-Drug Conjugates: Key Driver of Progress in HER2-Dependent Metastatic Breast Cancer Treatment 07/10/2024 World-Wide Clinical Perspectives from Chinese Society of Clinical Oncology's Globally Upscale 2024 Annual Meeting 04/10/2024 Breastfeeding is Safe After Treatment for BRCA-Positive Breast Cancer 04/10/2024 Breastfeeding is Safe After Treatment for BRCA-Positive Breast Cancer 27/09/2024 Breastfeeding After Hormone Receptor-Positive Breast Cancer: No Detectable Risk for Patients 26/09/2024 Findings at ESMO 2024 Highlighting the Benefit of Neoadjuvant Therapies 26/09/2024 HPV Vaccination Prevents HIV-Related Cancers in Men 10/07/2024 Proton Pump Inhibitors Bigger Impact on Dasatinib Efficacy in CML Than Previously Thought 09/07/2024 Immune-Related Adverse Events Predict Response to Checkpoint Inhibitor Monotherapy in Advanced Head & Neck Cancers 09/07/2024 A Multi-Drug Algorithm Used to Accurately Predict Best First-Line Treatments in Patients With Newly Diagnosed Acute Myeloid Leukemia 09/07/2024 MUC-1 Vaccine Delays Breast Cancer Distant Recurrence & Extends Survival 25/06/2024 Telehealth Triumphs for Palliative Care Delivery in Patients With Lung Cancer 25/06/2024 Lymphadenectomy Can Be Safely Omitted for Patients With Advanced Epithelial Ovarian Cancer Lacking Suspicious Lymph Nodes 25/06/2024 Neoadjuvant Checkpoint Inhibitor Combination Beats Standard Surgery With Adjuvant Immunotherapy in Macroscopic, Resectable Stage III Melanoma 25/06/2024 Asciminib May Be a Safer, More Effective Treatment for Patients With Newly Diagnosed Chronic Myeloid Leukemia 19/06/2024 Chemotherapy Before and After Surgery Improved Outcomes for Patients With Resectable Locally Advanced Esophageal Adenocarcinoma 18/06/2024 Trastuzumab Deruxtecan Delays Progression in HR+, HER2-low, and HER2 Ultralow Breast Cancer After Endocrine Therapy 18/06/2024 Study Supports Osimertinib as Standard of Care for Patients With Locally Advanced EGFR-Mutated NSCLC 11/06/2024 « Primera ‹ Anterior 1 2 3 4 5 Siguiente › Última » Share Facebook Twitter LinkedIn